Trump to Nominate Heidi Overton as FDA Commissioner
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Heidi Overton is expected to be nominated by Trump as the next FDA commissioner, according to a person familiar with the matter
- Overton has served as deputy director of domestic policy at the White House since the start of Trump's second term, leading health policy and working closely with HHS
- Overton has helped oversee signature administration health efforts including redesigning the food pyramid, overhauling the childhood vaccine schedule, and negotiating pricing deals with pharmaceutical companies
- Overton has at times frustrated leaders of the Make America Healthy Again movement, despite her central role in driving administration health policy
- The nomination will require Senate confirmation, with Overton facing scrutiny from a Senate panel before taking the FDA role
Why it matters: Overton's elevation would install a White House insider with direct responsibility for the administration's flagship health initiatives — food pyramid redesign, childhood vaccine schedule overhaul, and drug pricing — at the top of the agency that regulates the products those policies target. Her reported tensions with Make America Healthy Again leaders introduce an internal administration friction likely to surface during Senate confirmation.
Ask SkimNews
